Submit Your Abstract
Submissions must be completed by March 1, 2011.
The Scientific Committee of the 8th International Conference on Cryptococcus and Cryptococcosis (8th ICCC) invites the submissions of abstracts for oral and poster presentations during the conference scheduled for May 1-5, 2011, at the Francis Marion Hotel, Historic Charleston, South Carolina, USA.
The goals of the conferences are: 1) to bring together established and young investigators who study Cryptococcus and cryptococcosis; 2) to assess our current understanding of the molecular mechanisms by which Cryptococcus can invade the host and to cause disease; 3) to discuss recent sequencing of the Cryptococcus genomes, as well as the availability of new molecular tools to facilitate advances in understanding virulence, sexual reproduction, signaling, molecular pathogenesis, therapy, and vaccine development; and 4) to develop a new research and clinical agenda for the study and treatment of cryptococcosis. Abstracts should focus on the topics/goals illustrated above.
All concurrent session and poster presenters must register for the conference.
Click here to Register online.
Completed abstract packets must be submitted online by March 1, 2011. Only online submissions will be accepted!
Selection and Notification
Abstracts will be evaluated by the scientific review committee of the 8th ICCC. Criteria for abstract selection will include importance of topic relative to focus areas, congruence with conference theme and presenter qualifications.
Notification of accepted abstracts and commitment for presentation at the conference will be made by April 1, 2011.
Professional healthcare providers in a variety of roles and settings are invited to submit an abstract.
1. Abstracts may be submitted for concurrent and/or poster presentation.
2. Abstracts should be 400 words or fewer and typed single-spaced using a 10-12 point Arial font.
3. Abstract packets for each presentation must be complete and include the following:
- Applicant information form for each presenter (name and credentials exactly as they should appear in published materials or APA format)
Oral Presenters Only:
- A One-page current curriculum vitae for each oral presenter. Include your current and past working positions, education, honors/awards and your top 5 publications in your field of study. Do NOT include past, pending or current grant support.
4. Abstracts will be evaluated by the 8th ICCC Scientific Committee and some will be selected for oral presentation. Thus, if you wish your abstract to be considered for oral presentation, please select “Oral and Poster”. If you wish to present your work as a poster, please select “Poster Only”. If your abstract will be selected for oral presentation, you will also be required to present the Poster.
If accepted, the abstract will be published in the syllabus as submitted.
5. If abstract is accepted, the early registration rate will apply only to the person submitting the application if it is after the early registration date. One individual per abstract application will receive the early registration conference rate following the deadline.
The applicant is responsible for the abstract content and will be considered the main contact. Submission signifies the intent of the applicant to present the work at the 8th ICCC in Charleston South Carolina, May 1-5, 2011.
Please note that 8th ICCC cannot waive registration fees or reimburse expenses for accepted poster presenters. A registration fee is associated with all events and speakers are required to register.
If you have questions about the abstract submission, please contact the conference coordinator Pamela Benjamin at (843) 876-1925 or Benjamin@musc.edu.
Requests for withdrawal of an abstract must be received in writing no later than March 1, 2011.
1. The text should include the following sections, although they do not need to be separated: background, rationale, methods, results, discussion/conclusion. Briefly describe the objectives of the study. Include a brief statement of methods if pertinent. State findings in detail sufficient to support conclusions. Abstracts should not describe research in which the chemical identity or source of the reagent is proprietary or cannot be revealed.
2. Use generic drug names.
3. Do not begin sentences with numerals.
4. Standard abbreviations may be used without definition. Nonstandard abbreviations (kept to a minimum) must be placed in parentheses after the first use of the word or phrase abbreviated.
5. Do not include references, credits or grant support.
6. Do not include the names or personal information of any patient participating in the study or trial.
7. Graphic/Table. Addition of a graphic or a table deducts 250 characters.
Tips for a Successful Abstract:
Keep abstract titles brief and to the point. Use title case for abstract titles (ex. A Novel Curriculum for Systems-Based Practice); do not use all capital letters.
- Abstract descriptions should be no longer than 400 words. While abstracts will not be stringently judged on length, abstracts far in excess of 400 words may not be reviewed.
- List the first and last name of ALL authors. If including first or middle initials, do not insert periods after initials (ex. John M Jones). Do not include medical or doctoral degree suffixes in the author(s) listing.
- List institutional affiliations for ALL authors. If multiple authors are from the same institution, you may list them together (ex. John Jones, Mary Smith, Medical University of SC).
- Do not use symbols and spell out Greek letters.
- Single-space all text in the body of the abstract.
- Check and recheck all spelling, punctuation, and data for accuracy. Beware of formatting in the body of the abstract. Formatted text (bold and italics) or special characters may not transmit properly. If necessary, in place of italics, surround the phrase that needs to be italicized with " " marks.
- If possible, do not include graphic aids such as charts, tables, or graphs as these may affect the format of the abstract submission.
Back to Top of Page